Business
Politics
World News
Stock

RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

by June 11, 2025

June 11, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

Download the PDF here.

This post appeared first on investingnews.com

previous post

Argentina top court draws curtain on Cristina Kirchner’s political era

next post

Rapid Increases Land Holding by 26 X

You may also like

Bearish Divergence Suggests Caution For S&P 500

June 14, 2025

Is a Bold Rotation Brewing in Healthcare and...

June 14, 2025

Three Sectors Stand Out and One Sports a...

June 14, 2025

Harvest Gold Announces Annual General Meeting Results

June 13, 2025

Brunswick Exploration Announces AGM Results

June 13, 2025

Grande Portage Closes Non-Brokered Private Placement Pursuant to...

June 13, 2025

LaFleur Minerals

June 13, 2025

Juggernaut Exploration

June 13, 2025

Kalgoorlie Gold Mining

June 13, 2025

Lithium Africa

June 13, 2025

Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

Bearish Divergence Suggests Caution For S&P 500

June 14, 2025
Is a Bold Rotation Brewing in Healthcare and Biotech? Here’s What to Watch Now

June 14, 2025
Three Sectors Stand Out and One Sports a Bullish Breakout

June 14, 2025
David Beckham, Gary Oldman and Roger Daltrey knighted in King’s Birthday Honours

June 13, 2025
Israel’s unprecedented attack shows Iran has become a ‘playground’ for the Mossad

June 13, 2025
Harvest Gold Announces Annual General Meeting Results

June 13, 2025

About us
Contact us
Privacy Policy
Terms & Conditions

Disclaimer: venturecapitalvisions.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 venturecapitalvisions.com | All Rights Reserved

Business
Politics
World News
Stock